Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival
Authors
Keywords
-
Journal
OncoImmunology
Volume 4, Issue 5, Pages e1005460
Publisher
Informa UK Limited
Online
2015-05-21
DOI
10.1080/2162402x.2015.1005460
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of the IL-22/IL-22R1 axis in cancer
- (2014) Chrissie Lim et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Clinical significance of interleukin-22 in multiple myeloma
- (2014) George Tsirakis et al. Hematology
- IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L
- (2014) Ilona Kryczek et al. IMMUNITY
- Increased Intratumoral Interleukin 22 Levels and Frequencies of Interleukin 22–Producing CD4+ T Cells Correlate With Pancreatic Cancer Progression
- (2014) Xuejun Xu et al. PANCREAS
- Tumor antigen-specific CD4+T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies
- (2014) M. P. Protti et al. TISSUE ANTIGENS
- Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma
- (2014) Pascal Gelebart et al. Translational Oncology
- Role of IL-22- and TNF- -Producing Th22 Cells in Uveitis Patients with Behcet's Disease
- (2013) S. Sugita et al. JOURNAL OF IMMUNOLOGY
- Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance
- (2013) C Bryant et al. Blood Cancer Journal
- Increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival
- (2012) Yuan Zhuang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin 22-producing CD4+ T cells in malignant pleural effusion
- (2012) Zhi-Jian Ye et al. CANCER LETTERS
- Pro-tumour activity of interleukin-22 in HPAFII human pancreatic cancer cells
- (2012) L. M. Curd et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
- (2012) H Avet-Loiseau et al. LEUKEMIA
- Can we change the disease biology of multiple myeloma?
- (2012) Ivan Borrello LEUKEMIA RESEARCH
- Defining the human T helper 17 cell phenotype
- (2012) Francesco Annunziato et al. TRENDS IN IMMUNOLOGY
- Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
- (2011) Runqiu Jiang et al. HEPATOLOGY
- Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
- (2011) Lucia De Monte et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22
- (2011) Gregory F Sonnenberg et al. NATURE IMMUNOLOGY
- Treatment of multiple myeloma
- (2011) S. Vincent Rajkumar Nature Reviews Clinical Oncology
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma
- (2010) K. Noonan et al. BLOOD
- Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
- (2010) R. H. Prabhala et al. BLOOD
- Multiple myeloma: biology of the disease
- (2010) Anuj Mahindra et al. BLOOD REVIEWS
- Emerging therapies for the treatment of relapsed or refractory multiple myeloma
- (2010) Meletios A. Dimopoulos et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Biology of interleukin-22
- (2010) Kerstin Wolk et al. Seminars in Immunopathology
- Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
- (2009) Dharminder Chauhan et al. CANCER CELL
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
- (2009) Kristine E. Nograles et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells
- (2009) Sara Trifari et al. NATURE IMMUNOLOGY
- Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
- (2009) Thomas Duhen et al. NATURE IMMUNOLOGY
- Staging Systems and Prognostic Factors as a Guide to Therapeutic Decisions in Multiple Myeloma
- (2009) Marie-Christine Kyrtsonis et al. SEMINARS IN HEMATOLOGY
- Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma
- (2008) K. M. Dhodapkar et al. BLOOD
- Antiapoptotic Activity of Autocrine Interleukin-22 and Therapeutic Effects of Interleukin-22-Small Interfering RNA on Human Lung Cancer Xenografts
- (2008) W. Zhang et al. CLINICAL CANCER RESEARCH
- Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma
- (2008) J Dien Bard et al. LEUKEMIA
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now